chr2-232545678-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005199.5(CHRNG):​c.1516C>T​(p.Pro506Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0081 in 1,614,182 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P506P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0054 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 74 hom. )

Consequence

CHRNG
NM_005199.5 missense

Scores

1
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 3.00

Publications

5 publications found
Variant links:
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
TIGD1 (HGNC:14523): (tigger transposable element derived 1) The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B. The exact function of this gene is not known. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008921087).
BP6
Variant 2-232545678-C-T is Benign according to our data. Variant chr2-232545678-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 235605.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00536 (817/152328) while in subpopulation SAS AF = 0.00932 (45/4828). AF 95% confidence interval is 0.00804. There are 4 homozygotes in GnomAd4. There are 345 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNGNM_005199.5 linkc.1516C>T p.Pro506Ser missense_variant Exon 12 of 12 ENST00000651502.1 NP_005190.4 P07510-1A0A6F7YAP6
TIGD1NM_145702.4 linkc.*2429G>A 3_prime_UTR_variant Exon 1 of 1 ENST00000408957.7 NP_663748.1 Q96MW7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNGENST00000651502.1 linkc.1516C>T p.Pro506Ser missense_variant Exon 12 of 12 NM_005199.5 ENSP00000498757.1 P07510-1
CHRNGENST00000389492.3 linkc.1360C>T p.Pro454Ser missense_variant Exon 11 of 11 1 ENSP00000374143.3 P07510-2
TIGD1ENST00000408957.7 linkc.*2429G>A 3_prime_UTR_variant Exon 1 of 1 6 NM_145702.4 ENSP00000386186.3 Q96MW7

Frequencies

GnomAD3 genomes
AF:
0.00536
AC:
816
AN:
152210
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00911
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00861
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00672
AC:
1688
AN:
251260
AF XY:
0.00730
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00626
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00449
Gnomad NFE exome
AF:
0.00914
Gnomad OTH exome
AF:
0.00750
GnomAD4 exome
AF:
0.00839
AC:
12265
AN:
1461854
Hom.:
74
Cov.:
32
AF XY:
0.00851
AC XY:
6191
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33480
American (AMR)
AF:
0.00230
AC:
103
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00585
AC:
153
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0109
AC:
937
AN:
86258
European-Finnish (FIN)
AF:
0.00554
AC:
296
AN:
53388
Middle Eastern (MID)
AF:
0.00589
AC:
34
AN:
5768
European-Non Finnish (NFE)
AF:
0.00922
AC:
10251
AN:
1112006
Other (OTH)
AF:
0.00753
AC:
455
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
757
1515
2272
3030
3787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00536
AC:
817
AN:
152328
Hom.:
4
Cov.:
32
AF XY:
0.00463
AC XY:
345
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41574
American (AMR)
AF:
0.00470
AC:
72
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00932
AC:
45
AN:
4828
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00861
AC:
586
AN:
68026
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00760
Hom.:
8
Bravo
AF:
0.00517
TwinsUK
AF:
0.00890
AC:
33
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00872
AC:
75
ExAC
AF:
0.00678
AC:
823
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CHRNG: BS1, BS2 -

Dec 23, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2025
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive multiple pterygium syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CHRNG-related disorder Benign:1
Aug 25, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Lethal multiple pterygium syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;.
Eigen
Benign
0.17
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.85
D;D
MetaRNN
Benign
0.0089
T;T
MetaSVM
Uncertain
0.033
D
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
3.0
PrimateAI
Uncertain
0.56
T
PROVEAN
Pathogenic
-4.8
D;D
REVEL
Uncertain
0.41
Sift
Benign
0.040
D;D
Sift4G
Uncertain
0.051
T;T
Polyphen
0.36
B;.
Vest4
0.13
MVP
0.85
MPC
0.33
ClinPred
0.029
T
GERP RS
4.5
Varity_R
0.29
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71421651; hg19: chr2-233410388; COSMIC: COSV99033462; COSMIC: COSV99033462; API